BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: N’Kontchou G, Seror O, Bourcier V, Mohand D, Ajavon Y, Castera L, Grando-Lemaire V, Ganne-Carrie N, Sellier N, Trinchet JC. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17:179-184. [PMID: 15674095 DOI: 10.1097/00042737-200502000-00008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 79] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Saddekni S, Moustafa AS, Tahoon HA, Setita M, Abdel-Aal AK. Treatment of Hypersplenism by Partial Splenic Embolization Through Gastric Collaterals. J Radiol Case Rep 2016;10:28-35. [PMID: 27200164 DOI: 10.3941/jrcr.v10i3.2581] [Reference Citation Analysis]
2 Boyer TD, Habib S. Big spleens and hypersplenism: fix it or forget it? Liver Int. 2015;35:1492-1498. [PMID: 25312770 DOI: 10.1111/liv.12702] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
3 Farrell C, Hayes SC, Wire M, Zhang J. Population pharmacokinetic/pharmacodynamic modelling of eltrombopag in healthy volunteers and subjects with chronic liver disease. Br J Clin Pharmacol 2014;77:532-44. [PMID: 24117976 DOI: 10.1111/bcp.12244] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
4 Petermann A, Chabrot P, Cassagnes L, Dumousset E, Alfidja A, Gageanu C, Ravel A, Abergel A, Boyer L. Hypersplenism due to portal hypertension: retrospective evaluation of 17 patients treated by splenic embolization. Diagn Interv Imaging. 2012;93:30-36. [PMID: 22277708 DOI: 10.1016/j.diii.2011.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
5 Sun X, Zhang A, Zhou T, Wang M, Chen Y, Zhou T, Chen X, Xiu A, Peng Z, Cheng B, Liu X, Gao Y. Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial. Hepatol Int 2021;15:741-52. [PMID: 33638769 DOI: 10.1007/s12072-021-10155-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gangireddy VG, Kanneganti PC, Sridhar S, Talla S, Coleman T. Management of thrombocytopenia in advanced liver disease. Can J Gastroenterol Hepatol. 2014;28:558-564. [PMID: 25222481 DOI: 10.1155/2014/532191] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
7 Kauffman CR, Mahvash A, Kopetz S, Wolff RA, Ensor J, Wallace MJ. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy. Cancer. 2008;112:2283-2288. [PMID: 18344210 DOI: 10.1002/cncr.23432] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
8 Huang JH, Gao F, Gu YK, Li WQ, Lu LW. Combined treatment of hepatocellular carcinoma with partial splenic embolization and transcatheter hepatic arterial chemoembolization. World J Gastroenterol 2007; 13(48): 6593-6597 [PMID: 18161933 DOI: 10.3748/wjg.v13.i48.6593] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
9 Zhen C, Lishuang M, Jinshan Z, Guoliang Q, Zhen Z, Shuili L, Jun Z, Kaoping G, Long L; Wangchen. Safety and effectiveness of total splenic vessel ligations in paediatric patients with splenomegaly. J Minim Access Surg 2016;12:355-9. [PMID: 27609328 DOI: 10.4103/0972-9941.186689] [Reference Citation Analysis]
10 Zeng DB, Di L, Zhang RC, Guo QL, Duan BW, Jia CY, Chen F, Lin DD, Zang YJ, Lu SC. The Effect of Splenectomy on the Reversal of Cirrhosis: a Prospective Study. Gastroenterol Res Pract. 2019;2019:5459427. [PMID: 31093275 DOI: 10.1155/2019/5459427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Ooka Y, Chiba T, Ogasawara S, Motoyama T, Suzuki E, Tawada A, Kanai F, Yokosuka O. Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia. Biomed Res Int 2014;2014:960628. [PMID: 25298965 DOI: 10.1155/2014/960628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 Koconis KG, Singh H, Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: a review of the english language literature. J Vasc Interv Radiol. 2007;18:463-481. [PMID: 17446537 DOI: 10.1016/j.jvir.2006.12.734] [Cited by in Crossref: 73] [Cited by in F6Publishing: 61] [Article Influence: 5.2] [Reference Citation Analysis]
13 Nassef AA, Zakaria AA, Abd Elbary MS. Partial splenic artery embolization in portal hypertension patients with hypersplenism: Two interval-spaced sessions’ technique. The Egyptian Journal of Radiology and Nuclear Medicine 2013;44:531-7. [DOI: 10.1016/j.ejrnm.2013.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Zuchini R, Huang C, Tsai H, Huang S, Lin C, Chen C, Lee G, Lin X. Electromagnetic thermoablation to treat thrombocytopenia in cirrhotic and hypersplenic rats: Thermoablation for hypersplenism. Journal of Gastroenterology and Hepatology 2010;25:1578-86. [DOI: 10.1111/j.1440-1746.2010.06266.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhu K, Meng X, Li Z, Huang M, Guan S, Jiang Z, Shan H. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study. Eur J Radiol. 2008;66:100-106. [PMID: 17532166 DOI: 10.1016/j.ejrad.2007.04.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
16 Cai M, Huang W, Lin C, Li Z, Qian J, Huang M, Zeng Z, Huang J, Shan H, Zhu K. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. Eur Radiol 2016;26:370-80. [DOI: 10.1007/s00330-015-3839-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
17 Watanabe Y, Horiuchi A, Yoshida M, Yamamoto Y, Sugishita H, Kumagi T, Hiasa Y, Kawachi K. Significance of laparoscopic splenectomy in patients with hypersplenism. World J Surg. 2007;31:549-555. [PMID: 17308852 DOI: 10.1007/s00268-006-0504-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
18 Ishikawa T, Hamamoto K, Sasaki R, Nishimura T, Matsuda T, Iwamoto T, Takami T, Sakaida I. Significant improvement in portal‐systemic liver failure symptoms and successful management of portal‐splenic venous hemodynamics by the combination of interventional radiology and pharmacotherapy. Hepatol Res 2020;50:1201-8. [DOI: 10.1111/hepr.13545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Gu JJ, He XH, Li WT, Ji J, Peng WJ, Li GD, Wang SP, Xu LC. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiol. 2012;53:862-867. [PMID: 22855417 DOI: 10.1258/ar.2012.110639] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
20 Kobayashi K, Maruyama H, Kiyono S, Sekimoto T, Kondo T, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Portal response related to shunt occlusion by balloon-occluded retrograde transvenous obliteration may determine the prognosis of cirrhosis. Hepatol Res 2016;46:1321-9. [PMID: 26931092 DOI: 10.1111/hepr.12690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 Luz JH, Luz PM, Marchiori E, Rodrigues LA, Gouveia HR, Martin HS, Faria IM, Souza RR, Gil RA, Palladino AM, Pimenta KB, de Souza HS. Partial splenic embolization to permit continuation of systemic chemotherapy. Cancer Med 2016;5:2715-20. [PMID: 27611010 DOI: 10.1002/cam4.856] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
22 Wu Y, Li H, Zhang T, Bai Z, Xu X, Levi Sandri GB, Wang L, Qi X. Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis. Adv Ther 2021;38:1904-30. [PMID: 33687650 DOI: 10.1007/s12325-021-01652-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Zhu K, Meng X, Qian J, Huang M, Li Z, Guan S, Jiang Z, Shan H. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis. 2009;41:411-416. [PMID: 19070555 DOI: 10.1016/j.dld.2008.10.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 5.1] [Reference Citation Analysis]
24 Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Ishiko T, Baba H. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis. J Gastroenterol. 2010;45:554-559. [PMID: 20047119 DOI: 10.1007/s00535-009-0185-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
25 Cai M, Zhu K, Huang W, Meng X, He K, Zhou B, Guo Y, Chen J, Shan H. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up. J Vasc Interv Radiol. 2013;24:1808-1816. [PMID: 24099787 DOI: 10.1016/j.jvir.2013.08.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
26 Wang Q, Xiong B, Zheng C, Liang M, Han P. Splenic Arterial Embolization in the Treatment of Severe Portal Hypertension Due to Pancreatic Diseases: The Primary Experience in 14 Patients. Cardiovasc Intervent Radiol 2016;39:353-8. [PMID: 26304614 DOI: 10.1007/s00270-015-1199-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
27 Ozturk O, Eldem G, Peynircioglu B, Kav T, Görmez A, Cil BE, Balkancı F, Sokmensuer C, Bayraktar Y. Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension. World J Gastroenterol 2016; 22(43): 9623-9630 [PMID: 27920483 DOI: 10.3748/wjg.v22.i43.9623] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
28 Liu R, Teng XJ, He JF, Xiao SS, Yuan ZB, Li XJ, Gao XS, Zhou BM. Partial splenic embolization using Bletilla striata particles for hypersplenism in cirrhosis: a prospective study. Am J Chin Med. 2011;39:261-269. [PMID: 21476204 DOI: 10.1142/S0192415X11008804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
29 Lv Y, Lau WY, Li Y, Deng J, Han X, Gong X, Liu N, Wu H. Hypersplenism: History and current status. Exp Ther Med 2016;12:2377-82. [PMID: 27703501 DOI: 10.3892/etm.2016.3683] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
30 Aslanidou E, Fotoulaki M, Tsitouridis I, Nousia-arvanitakis S. Partial Splenic Embolization: Successful treatment of hypersplenism, secondary to biliary cirrhosis and portal hypertension in cystic fibrosis. Journal of Cystic Fibrosis 2007;6:212-4. [DOI: 10.1016/j.jcf.2006.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
31 Zhou J, Wu Z, Pankaj P, Peng B. Long-term postoperative outcomes of hypersplenism: laparoscopic versus open splenectomy secondary to liver cirrhosis. Surg Endosc. 2012;26:3391-3400. [PMID: 22648114 DOI: 10.1007/s00464-012-2349-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
32 Blonski W, Siropaides T, Reddy KR. Coagulopathy in liver disease. Curr Treat Options Gastroenterol 2007;10:464-73. [PMID: 18221607 DOI: 10.1007/s11938-007-0046-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
33 Pålsson B, Verbaan H. Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection. Eur J Gastroenterol Hepatol 2005;17:1153-5. [PMID: 16215425 DOI: 10.1097/00042737-200511000-00001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
34 Chao CP, Nguyen JH, Paz-Fumagalli R, Dougherty MK, Stockland AH. Splenic embolization in liver transplant recipients: early outcomes. Transplant Proc. 2007;39:3194-3198. [PMID: 18089351 DOI: 10.1016/j.transproceed.2007.07.089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
35 Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008;95:744-750. [PMID: 18412294 DOI: 10.1002/bjs.6081] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
36 Talwar A, Gabr A, Riaz A, Desai K, Thornburg B, Mouli S, Lewandowski RJ, Salem R. Adverse Events Related to Partial Splenic Embolization for the Treatment of Hypersplenism: A Systematic Review. J Vasc Interv Radiol 2020; 31: 1118-1131. e6. [PMID: 32014400 DOI: 10.1016/j.jvir.2019.08.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
37 Elmonem SA, Tantawy HI, Ragheb AS, Matar NE, Tantawi I. The outcome of partial splenic embolization for hypersplenism in the cirrhotic patients. The Egyptian Journal of Radiology and Nuclear Medicine 2011;42:35-42. [DOI: 10.1016/j.ejrnm.2011.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
38 Xu ZJ, Zheng LQ, Pan XN. Partial embolization as re-treatment of hypersplenism after unsuccessful splenic artery ligation. World J Gastroenterol 2015; 21(4): 1365-1370 [PMID: 25632215 DOI: 10.3748/wjg.v21.i4.1365] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Bárcena R, Moreno A, Foruny JR, Blázquez J, Graus J, Riesco JM, Blesa C, García-hoz F, Sánchez J, Gil-grande L, Nuño J, Fortún J, Rodriguez-sagrado MA, Moreno A. Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome: Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients. Clinical Transplantation 2010;24:366-74. [DOI: 10.1111/j.1399-0012.2009.01081.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
40 Elfeki M, Paz-fumagalli R, Tiemeier A, Pungpapong S, Sella D, Frey G, Musto K, Nguyen J, Harnois D. Choice of Partial Splenic Embolization Technique in Liver Transplant Recipients Correlates With Risk of Infectious Complications. Transplantation Proceedings 2015;47:2932-8. [DOI: 10.1016/j.transproceed.2015.10.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
41 Liu Q, Ma K, Song Y, Zhou N, He Z. Two-year follow-up of splenic radiofrequency ablation in patients with cirrhotic hypersplenism: does increased hepatic arterial flow induce liver regeneration? Surgery 2008;143:509-18. [PMID: 18374048 DOI: 10.1016/j.surg.2007.11.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
42 Shigekawa Y, Uchiyama K, Takifuji K, Ueno M, Hama T, Hayami S, Tamai H, Ichinose M, Yamaue H. A Laparoscopic Splenectomy Allows the Induction of Antiviral Therapy for Patients with Cirrhosis Associated with Hepatitis C Virus. The American Surgeon 2011;77:174-9. [DOI: 10.1177/000313481107700216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Ou MC, Chuang MT, Lin XZ, Tsai HM, Chen SY, Liu YS. A novel method for the angiographic estimation of the percentage of spleen volume embolized during partial splenic embolization. Eur J Radiol 2013;82:1260-5. [PMID: 23422281 DOI: 10.1016/j.ejrad.2013.01.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
44 Hayashi H, Beppu T, Masuda T, Mizumoto T, Takahashi M, Ishiko T, Takamori H, Kanemitsu K, Hirota M, Baba H. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol. 2007;22:1638-1642. [PMID: 17683504 DOI: 10.1111/j.1440-1746.2007.05090.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
45 Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: A review. World J Gastroenterol 2014; 20(10): 2595-2605 [PMID: 24627595 DOI: 10.3748/wjg.v20.i10.2595] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 53] [Article Influence: 8.6] [Reference Citation Analysis]
46 Hadduck TA, McWilliams JP. Partial splenic artery embolization in cirrhotic patients. World J Radiol 2014; 6(5): 160-168 [PMID: 24876920 DOI: 10.4329/wjr.v6.i5.160] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 29] [Article Influence: 5.9] [Reference Citation Analysis]
47 Zhu JH, Wang YD, Ye ZY, Zhao T, Zhu YW, Xie ZJ, Liu JM. Laparoscopic versus open splenectomy for hypersplenism secondary to liver cirrhosis. Surg Laparosc Endosc Percutan Tech. 2009;19:258-262. [PMID: 19542858 DOI: 10.1097/sle.0b013e3181a6ec7c] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
48 Zhan XL, Ji Y, Wang YD. Laparoscopic splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension. World J Gastroenterol 2014; 20(19): 5794-5800 [PMID: 24914339 DOI: 10.3748/wjg.v20.i19.5794] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
49 Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 13.2] [Reference Citation Analysis]
50 Martins GLP, Bernardes JPG, Rovella MS, Andrade RG, Viana PCC, Herman P, Cerri GG, Menezes MR. Radiofrequency ablation for treatment of hypersplenism: A feasible therapeutic option. World J Gastroenterol 2015; 21(20): 6391-6397 [PMID: 26034376 DOI: 10.3748/wjg.v21.i20.6391] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
51 Gonsalves CF, Mitchell EP, Brown DB. Management of Hypersplenism by Partial Splenic Embolization With Ethylene Vinyl Alcohol Copolymer. American Journal of Roentgenology 2010;195:1241-4. [DOI: 10.2214/ajr.10.4401] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kushiya H, Noji T, Abo D, Soyama T, Tanaka K, Nakanishi Y, Asano T, Nakamura T, Tsuchikawa T, Okamura K, Hirano S. Treatment of bleeding from a portion of pancreatojejunostomy after pancreaticoduodenectomy with division of the splenic vein: two case reports. Surg Case Rep 2019;5:128. [PMID: 31396775 DOI: 10.1186/s40792-019-0687-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
53 Lv Y, Wu H, Lau WY, Zheng J, Wu J, Zeng M. Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension. Sci Rep 2021;11:21246. [PMID: 34711891 DOI: 10.1038/s41598-021-00692-x] [Reference Citation Analysis]
54 Zhang L, Zhang ZG, Long X, Liu FL, Zhang WG. Severe Complications After Splenic Artery Embolization for Portal Hypertension Due to Hepatic Cirrhosis. Risk Manag Healthc Policy 2020;13:135-40. [PMID: 32110126 DOI: 10.2147/RMHP.S234628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Ohno T, Furui J, Hashimoto T, Hirabaru M, Kohno M, Iwao A, Koyamatsu J. Simultaneous laparoscopic hand-assisted hepatectomy and splenectomy for liver cancer with hypersplenism: report of a case. Surg Today 2011;41:444-7. [PMID: 21365435 DOI: 10.1007/s00595-010-4283-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
56 杨怀龙, 官泳松, 何志明, 王宏, 纪艳. 微导管和聚乙烯醇在部分脾栓塞中的应用. 世界华人消化杂志 2006; 14(34): 3284-3289 [DOI: 10.11569/wcjd.v14.i34.3284] [Reference Citation Analysis]
57 Zaitoun MMA, Basha MAA, Elsayed SB, El Deen DS, Zaitoun NA, Alturkistani H, Farag AA, Abdelsalam H, El-Kenawy HA, Mahmoud NEM, Alayouty NA, Eladl IM, Shahin S, Almarzooqi MK, Hendi AM, El-Morsy A, Elmokadem AH. Comparison of three embolic materials at partial splenic artery embolization for hypersplenism: clinical, laboratory, and radiological outcomes. Insights Imaging 2021;12:85. [PMID: 34173891 DOI: 10.1186/s13244-021-01030-5] [Reference Citation Analysis]
58 Beji H, De La Fouchardière C, Desseigne F, Thiesse P, Richioud B, Pilleul F. Thrombocytopenia due to hypersplenism in oncological disease: partial splenic embolization during palliative treatment. Diagn Interv Imaging 2015;96:383-6. [PMID: 25737395 DOI: 10.1016/j.diii.2014.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
59 Nakai M, Sato M, Sahara S, Kawai N, Kimura M, Maeda Y, Ibata Y, Higashi K. Transhepatic catheter-directed thrombolysis for portal vein thrombosis after partial splenic embolization in combination with balloon-occluded retrograde transvenous obliteration of splenorenal shunt. World J Gastroenterol 2006; 12(31): 5071-5074 [PMID: 16937510 DOI: 10.3748/wjg.v12.i31.5071] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
60 Maras D, Kontopodis N, Dedes A, Tsanis A, Mazarakis I, Gekas C, Ioannou CV. Selective Spleen Embolization of Splenomegaly to Improve Thrombocytopenia Facilitating Open Aortic Aneurysm Repair: A Staged Approach. Vasc Endovascular Surg 2016;50:438-42. [PMID: 27581226 DOI: 10.1177/1538574416666222] [Reference Citation Analysis]
61 Ogawa S, Yamamoto A, Jogo A, Nakano MM, Kageyama K, Sohgawa E, Nishida N, Kaminou T, Miki Y. Splenic Vein Diameter is a Risk Factor for the Portal Venous System Thrombosis After Partial Splenic Artery Embolization. Cardiovasc Intervent Radiol 2021;44:921-30. [PMID: 33474605 DOI: 10.1007/s00270-020-02751-8] [Reference Citation Analysis]
62 Abdella HM, Abd-El-Moez AT, Abu El-Maaty ME, Helmy AZ. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia. Indian J Gastroenterol. 2010;29:59-61. [PMID: 20443100 DOI: 10.1007/s12664-010-0013-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
63 Ohkoshi S, Yamagiwa S, Yano M, Takahashi H, Aoki YH, Matsuda Y, Aoyagi Y. Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention. Case Rep Gastroenterol 2010;4:261-6. [PMID: 20805953 DOI: 10.1159/000318742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
64 Senzolo M, Burra P, Cholongitas E, Burroughs A. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006; 12(48): 7725-7736 [PMID: 17203512 DOI: 10.3748/wjg.v12.i48.7725] [Cited by in CrossRef: 110] [Cited by in F6Publishing: 83] [Article Influence: 7.3] [Reference Citation Analysis]
65 He XH, Gu JJ, Li WT, Peng WJ, Li GD, Wang SP, Xu LC, Ji J. Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism. World J Gastroenterol 2012; 18(24): 3138-3144 [PMID: 22791950 DOI: 10.3748/wjg.v18.i24.3138] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
66 Annicchiarico BE, Siciliano M, Di Stasi C, Bombardieri G. Proximal splenic artery embolization allows pegylated interferon and ribavirin combination therapy in chronic hepatitis C virus-infected patients with severe cytopenia: . European Journal of Gastroenterology & Hepatology 2006;18:119-21. [DOI: 10.1097/00042737-200601000-00023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
67 Amin MA, El Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial Splenic Embolization Versus Splenectomy for the Management of Hypersplenism in Cirrhotic Patients. World J Surg 2009;33:1702-10. [DOI: 10.1007/s00268-009-0095-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
68 Ćwikiel W. Interventional procedures involving portal vein circulation: a review. Acta Radiol 2006;47:145-56. [DOI: 10.1080/02841850500466567] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
69 Huang Y, Ren D, Gao F, Ding Y, Cheng H, Huang X, Xu X. An updated meta-analysis of partial splenic embolization versus splenectomy in the treatment of hypersplenism due to cirrhosis. Minim Invasive Ther Allied Technol 2021;:1-12. [PMID: 34106805 DOI: 10.1080/13645706.2021.1933535] [Reference Citation Analysis]
70 Lv Y, Yee Lau W, Wu H, Han X, Gong X, Liu N, Yue J, Li Q, Li Y, Deng J. Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly. Exp Biol Med (Maywood). 2017;242:744-749. [PMID: 28299974 DOI: 10.1177/1535370217693113] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
71 Ikezawa K, Naito M, Yumiba T, Iwahashi K, Onishi Y, Kita H, Nishio A, Kanno T, Matsuura T, Ono A. Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection. J Viral Hepat. 2010;17:488-492. [PMID: 19840366 DOI: 10.1111/j.1365-2893.2009.01211.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
72 He XH, Li WT, Peng WJ, Li GD, Wang SP, Xu LC. Total embolization of the main splenic artery as a supplemental treatment modality for hypersplenism. World J Gastroenterol 2011; 17(24): 2953-2957 [PMID: 21734807 DOI: 10.3748/wjg.v17.i24.2953] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
73 Lo CJ, Chen CY, Tsai HW, Zuchini R, Lee GB, Lin XZ. Partial splenectomy using an electromagnetic thermal surgery system in a porcine model. Int J Hyperthermia 2011;27:108-15. [PMID: 21204624 DOI: 10.3109/02656736.2010.530637] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
74 Assal F, El Kassas M, Esmail E, Elbadry AA, Abousaif S, Mahdy R, Elfert A. Microwave ablation in the spleen versus partial splenic artery embolisation: A new technique for hypersplenism in cirrhosis. Arab J Gastroenterol 2017;18:25-9. [PMID: 28256406 DOI: 10.1016/j.ajg.2017.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
75 Guan YS, Hu Y. Clinical application of partial splenic embolization. ScientificWorldJournal. 2014;2014:961345. [PMID: 25538966 DOI: 10.1155/2014/961345] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
76 Trotter JF. Coagulation Abnormalities in Patients Who Have Liver Disease. Clinics in Liver Disease 2006;10:665-78. [DOI: 10.1016/j.cld.2006.08.006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
77 Chang CY, Singal AK, Ganeshan SV, Schiano TD, Lookstein R, Emre S. Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl 2007;13:1532-7. [DOI: 10.1002/lt.21317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
78 Vittorio J, Orellana K, Martinez M, Ovchinsky N, Schlossberg P, Griesemer A, Lobritto S. Partial Splenic Embolization Is a Safe and Effective Alternative in the Management of Portal Hypertension in Children. J Pediatr Gastroenterol Nutr 2019;68:793-8. [PMID: 30908386 DOI: 10.1097/MPG.0000000000002332] [Cited by in Crossref: 5] [Article Influence: 2.5] [Reference Citation Analysis]
79 相亭海, 杜顺达, 巩本刚, 成丕光, 吴俊本, 张同军, 夏修良. 门静脉高压症脾动脉栓塞术后再出血的断流术治疗. 世界华人消化杂志 2010; 18(15): 1605-1607 [DOI: 10.11569/wcjd.v18.i15.1605] [Reference Citation Analysis]
80 Bhatia SS, Venkat S, Echenique A, Rocha-lima C, Doshi MH, Salsamendi J, Barbery K, Narayanan G. Proximal Splenic Artery Embolization in Chemotherapy-Induced Thrombocytopenia: A Retrospective Analysis of 13 Patients. Journal of Vascular and Interventional Radiology 2015;26:1205-11. [DOI: 10.1016/j.jvir.2015.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]